Genetic Signatures Ltd (GSS) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.008x

Based on the latest financial reports, Genetic Signatures Ltd (GSS) has a cash flow conversion efficiency ratio of -0.008x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-349.00K ≈ $-246.94K USD) by net assets (AU$44.09 Million ≈ $31.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Genetic Signatures Ltd (GSS) total market value for the company's overall valuation and market capitalisation.

Genetic Signatures Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Genetic Signatures Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Genetic Signatures Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Genetic Signatures Ltd ranked by their cash flow conversion efficiency. Explore GSS cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Gti Energy Ltd AU:GTR	-0.033x
ShreeOswal Seeds And Chemicals Limited NSE:OSWALSEEDS	0.007x
E-Starco KO:015020	0.037x
Total Transport Systems Limited NSE:TOTAL	0.162x
TRIBECA RESOURCES CORPORA F:381	N/A
Turmalina Metals Corp V:TBX	0.012x
Spolytech Co. Ltd KQ:050760	0.084x
Sarytogan Graphite Ltd AU:SGA	0.039x

Annual Cash Flow Conversion Efficiency for Genetic Signatures Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Genetic Signatures Ltd from 2013 to 2025. View current stock price of Genetic Signatures Ltd for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$50.09 Million ≈ $35.44 Million	AU$-12.29 Million ≈ $-8.70 Million	-0.245x	-48.12%
2024-06-30	AU$61.10 Million ≈ $43.23 Million	AU$-10.12 Million ≈ $-7.16 Million	-0.166x	+42.92%
2023-06-30	AU$42.91 Million ≈ $30.36 Million	AU$-12.45 Million ≈ $-8.81 Million	-0.290x	-262.15%
2022-06-30	AU$54.80 Million ≈ $38.78 Million	AU$9.81 Million ≈ $6.94 Million	0.179x	+110.46%
2021-06-30	AU$49.34 Million ≈ $34.91 Million	AU$4.20 Million ≈ $2.97 Million	0.085x	+141.13%
2020-06-30	AU$45.93 Million ≈ $32.50 Million	AU$-9.49 Million ≈ $-6.72 Million	-0.207x	+3.71%
2019-06-30	AU$10.57 Million ≈ $7.48 Million	AU$-2.27 Million ≈ $-1.61 Million	-0.215x	+22.12%
2018-06-30	AU$13.40 Million ≈ $9.48 Million	AU$-3.69 Million ≈ $-2.61 Million	-0.276x	-76.69%
2017-06-30	AU$16.49 Million ≈ $11.66 Million	AU$-2.57 Million ≈ $-1.82 Million	-0.156x	+71.62%
2016-06-30	AU$4.68 Million ≈ $3.31 Million	AU$-2.57 Million ≈ $-1.82 Million	-0.550x	-38.78%
2015-06-30	AU$7.06 Million ≈ $4.99 Million	AU$-2.80 Million ≈ $-1.98 Million	-0.396x	-372.97%
2014-06-30	AU$16.18 Million ≈ $11.45 Million	AU$-1.35 Million ≈ $-958.56K	-0.084x	-123.40%
2013-06-30	AU$-3.32 Million ≈ $-2.35 Million	AU$-1.19 Million ≈ $-839.81K	0.358x	--

About Genetic Signatures Ltd

AU:GSS Australia Diagnostics & Research

Market Cap

$12.54 Million

AU$17.72 Million AUD

Market Cap Rank

#26560 Global

#1216 in Australia

Share Price

AU$0.08

Change (1 day)

+0.00%

52-Week Range

AU$0.05 - AU$0.38

All Time High

AU$2.75